These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23990671)

  • 1. Concerned about HPV-related cancer rise, researchers advocate boosting HPV vaccination rates.
    Azvolinsky A
    J Natl Cancer Inst; 2013 Sep; 105(18):1335-6. PubMed ID: 23990671
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papillomavirus-associated cancers - United States, 2004-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
    Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?
    Takes RP; Wierzbicka M; D'Souza G; Jackowska J; Silver CE; Rodrigo JP; Dikkers FG; Olsen KD; Rinaldo A; Brakenhoff RH; Ferlito A
    Oral Oncol; 2015 Dec; 51(12):1057-60. PubMed ID: 26520047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nongenital human papillomavirus disease.
    Mayeaux EJ; Khan MJ
    Obstet Gynecol Clin North Am; 2013 Jun; 40(2):317-37. PubMed ID: 23732034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunizing against Anogenital Cancer: HPV Vaccines.
    Pogoda CS; Roden RB; Garcea RL
    PLoS Pathog; 2016 May; 12(5):e1005587. PubMed ID: 27196109
    [No Abstract]   [Full Text] [Related]  

  • 7. [Papillomavirus, could we speak about cancer and prevention?].
    Pernot S; Pavie J; Péré H; Menard M; Hurel S; Cochand-Priollet B; Bats AS; Badoual C
    Bull Cancer; 2018 Feb; 105(2):137-139. PubMed ID: 29373106
    [No Abstract]   [Full Text] [Related]  

  • 8. The HPV infection in males: an update.
    Giraldi G; De Luca d'Alessandro E
    Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic human papillomavirus vaccines: past, present and future.
    Anderson LA
    Pathology; 2012 Jan; 44(1):1-6. PubMed ID: 22157686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Committee Opinion Summary No. 641: Human Papillomavirus Vaccination.
    Obstet Gynecol; 2015 Sep; 126(3):693. PubMed ID: 26287785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
    Kiellberg Larsen H; Kofoed K; Sand C
    Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
    Parkin DM; Louie KS; Clifford G
    Vaccine; 2008 Aug; 26 Suppl 12():M1-16. PubMed ID: 18945410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV vaccine: effective but underused in the US.
    Kamerow D
    BMJ; 2016 Apr; 353():i2060. PubMed ID: 27081105
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging human papillomavirus vaccines.
    Ma B; Maraj B; Tran NP; Knoff J; Chen A; Alvarez RD; Hung CF; Wu TC
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):469-92. PubMed ID: 23163511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV--Changing the Face of Head and Neck Cancer and Dental Societies' Responsibilities.
    Hayes C
    Todays FDA; 2015; 27(3):38-9. PubMed ID: 26523308
    [No Abstract]   [Full Text] [Related]  

  • 17. Extended coverage of HPV vaccination in middle-aged adults to prevent oropharyngeal cancers.
    Arya SC; Agarwal N
    Hum Vaccin Immunother; 2012 Jul; 8(7):959. PubMed ID: 22777098
    [No Abstract]   [Full Text] [Related]  

  • 18. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
    Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.
    Timbang MR; Sim MW; Bewley AF; Farwell DG; Mantravadi A; Moore MG
    Hum Vaccin Immunother; 2019; 15(7-8):1920-1928. PubMed ID: 31050595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts.
    Blomberg M; Friis S; Munk C; Bautz A; Kjaer SK
    J Infect Dis; 2012 May; 205(10):1544-53. PubMed ID: 22427679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.